14-day Premium Trial Subscription Try For FreeTry Free

Explanation to Bollinger's Bands

Bollinger Bands was created by John Bollinger in the early 1980s, its purpose is to define price action relative to the assets highs and lows. This technical indicator is used to identify buy and sell signals and has proven very well in doing so.

Bollinger Bands consist of a set of three curves drawn in relation to securities prices. The middle band is a measure of the intermediate-term trend, usually a simple moving average, that serves as the base for the upper and lower bands. The interval between the upper and lower bands and the middle band is determined by volatility, typically the standard deviation of the same data that were used for the average. StockInvest.us uses Bollingers suggested 20 day average.

Middle Bollinger Band = 20-period simple moving average
Upper Bollinger Band = Middle Bollinger Band + 2 * 20-period standard deviation
Lower Bollinger Band = Middle Bollinger Band - 2 * 20-period standard deviation

BandWidth defines the current width of the band.
%b defines the current position within the band.

BandWidth = (Upper Bollinger Band - Lower Bollinger Band) / Middle Bollinger Band
%b = (Last - Lower Bollinger Band) / (Upper Bollinger Band - Lower Bollinger Band)

Live Samples:

Bollinger Bottleneck Buy Pattern 1
Bollinger Bottleneck Buy Pattern 2
Bollinger Bottleneck Sell Pattern

Bottlenecks in bandwidth indicate an upcoming change. Break up through the moving average line or continuous movements above the moving average line indicate a break up, and vice versa.

Source: http://www.bollingerbands.com

RSI low/high Values: [ 25 - 80 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of PBLA
Powered by GPT-4o
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Strong day for Panbela Therapeutics Inc. stock price on Friday rising 10.53% to $0.420
(Updated on Jun 21, 2024)

Buy candidate since Jun 21, 2024 PDF

The Panbela Therapeutics Inc. stock price gained 10.53% on the last trading day (Friday, 21st Jun 2024), rising from $0.380 to $0.420. During the last trading day the stock fluctuated 0% from a day low at $0.420 to a day high of $0.420. The price has risen in 5 of the last 10 days and is up by 9.95% over the past 2 weeks. Volume fell on the last day by -20 thousand shares and in total, 235 shares were bought and sold for approximately $98.70 . You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies the upper part of a very wide and falling trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break up at the top trend line at $0.439 will firstly indicate a slower falling rate, but may be the first sign of a trend shift. Given the current short-term trend, the stock is expected to fall -34.43% during the next 3 months and, with a 90% probability hold a price between $0.181 and $0.288 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

PBLA Signals & Forecast

The Panbela Therapeutics Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $0.414 and $0.403. A breakdown below any of these levels will issue sell signals. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Monday, June 17, 2024, and so far it has fallen -6.67%. Further fall is indicated until a new bottom pivot has been found. Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may not be. The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Panbela Therapeutics Inc. stock

Panbela Therapeutics Inc. finds support from accumulated volume at $0.410 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0 between high and low, or 0%. For the last week the stock has had daily average volatility of 0.98%.

Our recommended stop-loss: $0.404 (-3.71%) (This stock has high daily movements and this gives high risk. There is a sell signal from a pivot top found 18 days ago.)

Trading Expectations (PBLA) For The Upcoming Trading Day Of Monday 24th

For the upcoming trading day on Monday, 24th we expect Panbela Therapeutics Inc. to open at $0.420, and during the day (based on 14 day Average True Range), to move between $0.371 and $0.469, which gives a possible trading interval of +/-$0.0490 (+/-11.67%) up or down from last closing price. If Panbela Therapeutics Inc. takes out the full calculated possible swing range there will be an estimated 23.34% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $0.410 (2.38%) than the resistance at $0.435 (3.63%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Panbela Therapeutics Inc. stock A Buy?

Several short-term signals are positive, despite the stock being in a falling trend, we conclude that the current level may hold a buying opportunity as there is a fair chance for stock to perform well in the short-term. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Buy candidate.

Current score: 2.108 Buy Candidate Upgraded

Predicted Opening Price for Panbela Therapeutics Inc. of Monday, June 24, 2024

Fair opening price June 24, 2024 Current price
$0.420 ( 0%) $0.420

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for PBLA

Fibonacci Support & Resistance Levels

Level Price
R3 0.420 -
R2 0.420 -
R1 0.420 -
Price 0.420
S1 0.420 -
S2 0.420 -
S3 0.420 -

Accumulated Volume Support & Resistance Levels

Level Price
R3 0.510 21.43%
R2 0.441 4.94%
R1 0.435 3.63%
Price 0.420
S1 0.410 -2.38%
S2 0.400 -4.76%
S3 0.380 -9.52%

FAQ

What is the symbol for Panbela Therapeutics Inc. Stock and on which exchange is it traded?
The symbol for Panbela Therapeutics Inc. is PBLA and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Panbela Therapeutics Inc. Stock?
Several short-term signals are positive, despite the stock being in a falling trend, we conclude that the current level may hold a buying opportunity as there is a fair chance for stock to perform well in the short-term. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Buy candidate.

How to buy Panbela Therapeutics Inc. Stock?
Panbela Therapeutics Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Panbela Therapeutics Inc. Stock.

What's the current price of Panbela Therapeutics Inc. Stock?
As of the end of day on the Jun 21, 2024, the price of an Panbela Therapeutics Inc. (PBLA) share was $0.420.

What is the 52-week high and low for Panbela Therapeutics Inc. Stock?
The 52-week high for Panbela Therapeutics Inc. Stock is $8.20 and the 52-week low is $0.350.

What is the market capitalization of Panbela Therapeutics Inc. Stock?
As of the Jun 21, 2024, the market capitalization of Panbela Therapeutics Inc. is 1.845M.

When is the next earnings date for Panbela Therapeutics Inc.?
The upcoming earnings date for Panbela Therapeutics Inc. is Aug 08, 2024.
Click to get the best stock tips daily for free!

About Panbela Therapeutics Inc.

Panbela Therapeutics. Panbela Therapeutics, Inc., a clinical-stage biopharmaceutical company, together with its subsidiaries, focuses on developing disruptive therapeutics for the treatment of patients with cancer. The company focuses on diseases of the pancreas, including pancreatitis and pancreatic cancer, as well as neoadjuvant pancreatic cancer, colorectal cancer, ovarian cancer, and other agents in other cancer indications. Its lead product candidate is SBP-101, ... PBLA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT